SUPRIYA LIFESCIENCE LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 773.60 INR | +2.75% |
|
+7.27% | +4.57% |
| Feb. 01 | Supriya Lifescience Limited Announces Board Changes | CI |
| Jan. 27 | Supriya Lifescience Limited, Q3 2025 Earnings Call, Jan 27, 2025 |
Chart calendar Supriya Lifescience Limited
281394802589816fa33d7a2b8b6.-h004e-Wx8VAab8zedCkrDgK1wGrgNTVMP2NepsOL24.vnlzm776rql0I81QK5rKnWhEn3D_-oujQb7OFvZXVialZQGAt_OuryEK3A~15f0a7e4f1e411286a56271f638c092a
Upcoming events on Supriya Lifescience Limited
Past events on Supriya Lifescience Limited
| 2025-01-27 12:00 am | Q3 2025 Earnings Call |
| 2025-01-24 05:47 am | Q3 2025 Earnings Release |
| 2025-01-06 | Investor Meeting |
| 2024-12-25 | Investor Meeting - JM Financial Institutional Securities Ltd |
| 2024-12-23 | Nuvama Management Connect Conference |
| 2024-12-22 | Investor Meeting - Emkay Global Financial Services Ltd |
| 2024-12-17 | Investor Meeting |
| 2024-12-02 | Investor Meeting - Purnartha Investment Advisers |
| 2024-12-02 | BOB Capital Markets Pharma Day |
| 2024-11-17 | Investor Meeting - Grandeur Peak Global Advisors |
| 2024-11-12 | Nirmal Bang Institutional Equities Conference |
| 2024-10-28 06:00 am | Q2 2025 Earnings Call |
| 2024-10-28 04:19 am | Q2 2025 Earnings Release |
| 2024-09-27 05:30 am | Annual General Meeting |
| 2024-09-23 | Investor Meeting - Electrum PMS ADD Capital |
| 2024-09-18 | Investor Meeting - Phillip Capital PCG |
| 2024-09-17 | Investor Meeting - Grandeur Peak Global Advisors |
| 2024-09-12 | Investor Meeting - Supriya Lifescience Limited |
| 2024-09-05 | Investor Meeting - Ambit Wealth Management |
| 2024-09-03 | Investor Meeting - Julius Baer |
Past dividends on Supriya Lifescience Limited
| 2024-09-19 | Annual 0.8 INR |
| 2023-09-14 | Annual 0.6 INR |
| 2022-08-31 | Annual 0.6 INR |
Annual results
| Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 0,00 | 4 609 4 296 7.29% | 5 704 5 617 1.54% | 7 042 | 8 521 | 10 310 |
|
EBITDA Million INR | Released Forecast Spread | 0,00 | 1 289 120 974.14% | 1 730 1 628 6.25% | 2 450 | 2 556 | 3 145 |
|
EBIT Million INR | Released Forecast Spread | 0,00 | 0,00 0,00 - | 1 572 1 469 6.99% | 2 256 | 2 320 | 2 872 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 0,00 | 1 235 835 47.89% | 1 657 1 565 5.87% | 2 329 | 2 427 | 3 007 |
|
Net income Million INR | Released Forecast Spread | 1 518 | 899 618 45.4% | 1 191 1 148 3.78% | 1 738 | 1 815 | 2 248 |
|
EPS INR | Released Forecast Spread | 18,9 | 11,2 7,70 44.94% | 14,8 14,3 3.5% | 21,6 | 22,5 | 27,9 |
| Announcement Date | 20/05/22 | 26/05/23 | 28/05/24 | - |
Quarterly results
| Fiscal Period | March | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 1 122 1 275 -12.02% | 1 423 1 110 28.17% | 1 320 1 341 -1.55% | 1 401 1 345 4.16% | 1 401 1 211 15.67% | 1 582 1 495 5.81% | 1 606 1 686 -4.73% | 1 681 | ||
|
EBITDA Million INR | Released Forecast Spread | 515 425 21.28% | 550 150 266.97% | 445 385 15.56% | 318 400 -20.62% | 415 341 21.67% | 555 453 22.53% | 625 489 27.9% | 488 | 483 | |
|
Net income Million INR | Released Forecast Spread | 95,2 | 446 351 27.19% | ||||||||
|
EPS INR | Released Forecast Spread | 1,18 | |||||||||
| Announcement Date | 10/11/22 | 14/02/23 | 26/05/23 | 03/08/23 | 07/11/23 | 07/02/24 | 28/05/24 | 10/08/24 | - | - |
| Today 07:00 am | ROIVANT SCIENCES LTD.: Q3 2024 Earnings Release |
| 2025-02-10 | ROYALTY PHARMA PLC: Q4 2024 Earnings Release |
| 2025-02-10 | LUPIN LIMITED: Q3 2025 Earnings Release |
| 2025-02-10 | MARKSANS PHARMA LIMITED: Q3 2025 Earnings Release |
| 2025-02-10 | ASTRAZENECA PHARMA INDIA LIMITED: Q3 2025 Earnings Release |
| 2025-02-11 04:02 pm | GILEAD SCIENCES, INC.: Q4 2024 Earnings Release |
| 2025-02-11 | CORCEPT THERAPEUTICS INCORPORATED: Q4 2024 Earnings Release (Projected) |
| 2025-02-11 | NATCO PHARMA LIMITED: Q3 2025 Earnings Release |
| 2025-02-11 | SUVEN PHARMACEUTICALS LIMITED: Q3 2025 Earnings Release |
| 2025-02-11 | ROHTO PHARMACEUTICAL CO.,LTD.: Q3 2024 Earnings Release |
Past sector events for Supriya Lifescience Limited
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SUPRIYA Stock
- Calendar Supriya Lifescience Limited